TNF and rheumatoid arthritis: NT-proBNP is a predictor of CV mortality and morbidity in patients with or without a history of CVD and RA patients [47,48,49] and in our study, a 23% NT-pro BNP decrease after 6 months anti-TNF treatment was observed.